Trial Profile
The potential effect of Dapagliflozin on diabetic macular edema
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 24 May 2016 New trial record